iShares Core MSCI International Developed Markets ETF (ARCA: IDEV)

Latest News for iShares Core MSCI International Developed Markets ETF (ARCA:IDEV)

iShares Core MSCI International Developed Markets ETF

Long Ideas

Specialty ETFs

Trading Ideas

ETFs

IDEV

A Rapidly Growing Developed Markets ETF

Broad U.S. Equity ETFs

New ETFs

Markets

ARKK

CXSE

SPDR Dow Jones Industrial Average ETF Trust

EMQQ

GAMR

SCIF

USMC

Why ETFs Are Thriving In 2017

News

Global

A Developed Markets Idea For Frugal Investors

Stephens &amp; Co. analyst John Campbell maintains First American Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FAF#NYSE">FAF</a>) with a Overweight and lowers the price target from $72 to $66.

Price Target

Analyst Ratings

Stephens & Co. Maintains Overweight on First American Financial, Lowers Price Target to $66

Baird analyst Jeffrey Meuler maintains TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) with a Outperform and raises the price target from $87 to $94.

Baird Maintains Outperform on TransUnion, Raises Price Target to $94

Increasing full year 2024 guidance Total revenue: ~12% Previously +11 - 12% Organic: ~6% Previously +5 - 6% Adjusted DEPS: $18.05 - $18.25 Previously $17.85 - $18.15

Guidance

Roper Technologies Expects FY24 Revenue Growth of ~12% YoY (Prior 11%-12%) Vs $6.89B Est, Organic Revenue Growth of ~6% YoY (Prior 5%-6%)

Baird analyst Rob Oliver maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and lowers the price target from $270 to $230.

TEAM

Baird Maintains Outperform on Atlassian, Lowers Price Target to $230

Castlebar Capital Corp. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/CBAR#TSXV">CBAR</a>) ("Castlebar" or the "Company") is pleased to announce that it has entered into a letter of intent dated April 25, 2024 (the "LOI") with Mosaic Minerals Corporation (CSE:<a class="ticker" href="https://www.benzinga.com/stock/MOC#CSE">MOC</a>) ("Mosaic"). Pursuant to the LOI, Castlebar will be granted an option to acquire (the "Transaction") up to a 100% interest in the Lichen Project (the "Lichen Project" or "Property"). The Transaction is intended to be Castlebar's "Qualifying Transaction" for purposes of the TSX Venture Exchange's (the "Exchange") Capital Pool Company program.
The Lichen Project consists of 282 claims covering a total area of 15,622 hectares and is located approximately 100 km west of the Chibougamau mining camp. The property is underlain by the volcanic rocks of the Obatogamau formation intruded by stocks and plutons of intermediate composition. The volcanic belt is parallel to two known gold bearing volcanic belt, the Bachelor Lake gold area to the west and the Osisko-Windfall gold area to the south. The Nelligan Gold project and The Monster Lake Gold project are located at the eastern extremity of the volcanic belt. Numerous gold and copper showings are also found to the east and to the west of the property.
Terms of the LOI: Pursuant to the LOI, Castlebar may acquire up to a 50% undivided interest (the "First Option") in the Lichen project from Mosaic by, among other things:
(i) make aggregate cash payments of $205,000 to Mosaic as follows:
$15,000 on the closing of Qualifying Transaction (the "Effective Date");
an additional $15,000 within six months following the Effective Date;
an additional $50,000 on or before the first anniversary of the Effective Date;
an additional $50,000 on or before the second anniversary of the Effective Date; and
an additional $75,000 on or before the third anniversary of the Effective Date; and
(ii) by issuing an aggregate of 1,350,000 shares to Mosaic as follows:
250,000 shares no later than seven days following the Effective Date;
an additional 350,000 shares on or before the first anniversary of the Effective Date;
an additional 250,000 shares on or before the second anniversary of the Effective Date; and
an additional 500,000 shares on or before the third anniversary of the Effective Date; and
(iii) by incurring at least $750,000 in qualifying expenditures on the Property as follows:
at least $150,000 in qualifying expenditures on the Property on or before the first anniversary of the Effective Date;
at least $200,000 in cumulative qualifying expenditures on the Property on or before the second anniversary of the Effective Date; and
at least $400,000 in cumulative qualifying expenditures on the Property on or before the third anniversary of the Effective Date.
Upon exercise of the First Option, Castlebar shall have forty-five (45) days to either (i) establish a joint venture with Mosaic in which each shall hold a 50% joint venture interest or (ii) exercise an additional option ("Additional Option") to acquire an additional 50% interest in the Property by making a $150,000 cash payment and issuing 1,500,000 shares to Mosaic within the forty-five (45) day period. If Castlebar exercises the Additional Option, then it will have earned 100% undivided interest in the Property free and clear of all encumbrances except for a 2% net smelter royalty to be retained by Mosaic. Castlebar may accelerate and carry forward any of the cash payments, share issuances or work expenditures.
Castlebar proposes to complete a private placement raising not less than $850,000 (the "Private Placement") to fund the phase one work program on the Lichen project and general and administrative operating expenses. Castlebar will complete a one-for-two stock split (the "Stock Split") immediately prior to closing of the Qualifying Transaction and Private Placement. The Qualifying Transaction, if completed, is an Arm's Length Qualifying Transaction. No Shareholder approval is required to complete the Qualifying Transaction. Further information in respect of the Private Placement and how the Company will meet the Exchange's Evidence of Value test will be provided in a subsequent news release.
Completion of the Transaction is subject to a number of conditions, including but not limited to, completion of due diligence by the parties, negotiation and execution of a definitive option agreement on the principal terms set forth in the LOI, Exchange acceptance, completion of the Stock Split and completion of the Private Placement. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the filing statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.
The Company has requested its common shares to be halted by the Exchange pending review of the materials for the Transaction. Trading in the common shares of the Company is expected to remain halted until the closing or termination of the Transaction. Upon completion of the Transaction, it is expected that the Company will be a Tier 2 Mining Issuer on the Exchange.
Castlebar, a capital pool company within the meaning of the policies of the Exchange, does not have any operations and has no assets other than cash. Castlebar's business is to identify and evaluate businesses and assets with a view to completing a Qualifying Transaction under the policies of the Exchange.
The Exchange has in no way passed upon the merits of the proposed Transaction and has neither approved nor disapproved the contents of this press release.

Contracts

Asset Sales

CSE:MOC

TSXV:CBAR

Reported April 25, 2024, Castlebar Capital Signs LOI with Mosaic Minerals To Acquire Up To A 100% Interest In The Lichen Project

Baird analyst Joe Vruwink maintains SPS Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPSC#NASDAQ">SPSC</a>) with a Neutral and raises the price target from $172 to $178.

SPSC

Baird Maintains Neutral on SPS Commerce, Raises Price Target to $178

WIIM

Centene shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales. Additionally, the company raised upbeat its guidance for 2024.

Over a week after a group of North Dakotans <a href="https://www.benzinga.com/markets/cannabis/24/04/38290781/north-dakotans-file-legal-marijuana-petition-cannabis-legalization-is-coming-and-its-coming-fast">filed a </a><a href="https://www.benzinga.com/markets/cannabis/24/04/38290781/north-dakotans-file-legal-marijuana-petition-cannabis-legalization-is-coming-and-its-coming-fast">2024 ballot measure petition</a> to legalize recreational cannabis, the state's top election official gave the green light for signature gathering to begin, <a href="https://abcnews.go.com/US/wireStory/recreational-marijuana-backers-gather-signatures-north-dakota-ballot-109652169">reported</a> ABC News.
The New Economic Frontier, a cannabis advocacy committee behind the push, needs to garner and submit 15,582 valid signatures to Secretary of State Michael Howe by July 8 in order to place the measure on the November general election ballot.
Under a measure's 20-page text, personal recreational marijuana use at home would be legal for those 21 and older. The measure proposes setting up a regulatory framework for the production and processing of cannabis as well as prohibited uses.
Steve Bakken, a Burleigh County commissioner and former Bismarck mayor, who is behind the initiative, said law enforcement resources "should be directed someplace a little more effectual."
Criminal defense attorney Mark Friese, who previously served as a Bismarck police officer, agreed with Bakken, adding that his efforts are directed toward preventing North Dakota from becoming an island of prohibition.
See also: <a href="https://www.benzinga.com/markets/cannabis/23/02/30707108/north-dakota-lawmakers-say-no-to-cannabis-edibles-heres-why-gop-led-house-killed-two-mmj-bills">North Dakota Lawmakers Say No To Cannabis Edibles, Here&#8217;s Why GOP-Led House Killed Two MMJ Bills</a>
"We spend too many resources, we spend too much money, we criminalize behavior that&#8217;s more benign than alcohol consumption, and we have a mental health and true drug crisis going on in our communities, and we&#8217;re diverting law enforcement resources away from methamphetamine and fentanyl to make marijuana arrests,&#8221; Friese said. &#8220;It&#8217;s just illogical.&#8221;
According to the sponsoring committee, the measure would also help boost the state&#8217;s economy. Marijuana products will be regulated and therefore much safer for consumers. The reform would make medical marijuana more accessible to veterans and individuals with various health conditions. 
Previous efforts in 2018 and 2022 to <a href="https://www.benzinga.com/markets/cannabis/22/11/29627576/north-dakota-loses-bid-to-legalize-adult-use-cannabis">legalize recreational cannabis in North Dakota failed. </a>Will the third time be the charm?
Now read: <a href="https://www.benzinga.com/markets/cannabis/22/10/29358919/religious-anti-marijuana-activists-are-getting-louder-ready-to-move-from-talk-to-action">Religious Anti-Marijuana Groups Are Getting Louder And Ready To Move From Talk To Action</a>

Cannabis

Government

Regulations

Politics

Legal

Third Time's The Charm? North Dakota Ballot Initiative Group Gets Green Light To Collect Signatures For Marijuana Legalization

Baird analyst Mark Marcon maintains Robert Half (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) with a Outperform and lowers the price target from $84 to $79.

Baird Maintains Outperform on Robert Half, Lowers Price Target to $79

Shares of Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) rose sharply in today's pre-market trading the company posted upbeat <a href="https://www.benzinga.com/news/earnings/24/04/38445001/alphabet-q1-earnings-revenue-beat-eps-beat-70b-buyback-first-ever-dividend-ai-leadership-and-more">results for its first quarter</a>.
Google parent Alphabet said its first-quarter revenue increased 15% year-over-year to $80.539 billion, beating the consensus estimate of $78.594 billion. The company reported quarterly earnings of $1.89 per share, beating analyst estimates of $1.51 per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Alphabet's board authorized an additional share repurchase program of up to $70 billion and also announced its first-ever quarterly dividend.
Alphabet shares jumped 11.9% to $174.58 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
<ul>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares gained 64.7% to $1.40 in pre-market trading after falling over 43% on Thursday.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) gained 40.5% to $0.0729 in pre-market trading.</li>
<li>Freight Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) climbed 32.4% to $1.21 in pre-market trading after gaining 5% on Thursday.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) gained 24.2% to $14.16 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company reported a year-over-year increase in quarterly daily active users.</li>
<li>Earlyworks Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) rose 20.7% to $0.88 in today's pre-market trading after gaining 19% on Thursday.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) shares gained 20.1% to $0.1898 in pre-market trading after gaining 15% on Thursday.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares gained 14.6% to $1.49 in pre-market trading after dipping 16% on Thursday.</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) shares rose 11.5% to $204.50 in pre-market trading after the company reported better-than-expected third-quarter financial results.</li>
<li>Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) shares gained 11% to $65.30 in pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aclarion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) fell 19.5% to $0.3161 in pre-market trading. Aclarion shares jumped 36% on Thursday after the company announced that its Nociscan solution will be used in the upcoming LIFEHAB trial evaluating the diagnosis and treatment of chronic low back pain.</li>
<li>Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) shares declined 16.4% to $0.75 in pre-market trading after the company announced pricing of underwritten public offering of common stock and warrants.</li>
<li>SCWorx Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) fell 16.3% to $2.31 pre-market trading after surging 36% on Thursday.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) fell 15.4% to $2.05 in pre-market trading. Processa Pharmaceuticals shares jumped 50% on Thursday after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and announced an $8 price target.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) fell 13.9% to $0.2238 pre-market trading after dipping 39% on Thursday. Chicken Soup For The Soul Entertainment received delinquency letter from the Nasdaq.</li>
<li>Northann Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCL#NYSE">NCL</a>) shares fell 13.6% to $0.4015 in pre-market trading after dipping 12% on Thursday.</li>
<li>Boyd Gaming Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) shares declined 12.6% to $55.00 in pre-market trading after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares fell 7.2% to $32.57 in pre-market trading after the company reported worse-than-expected first-quarter sales results and issued EPS guidance below estimates.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) shares fell 5.8% to $4.41 in pre-market trading after dipping 19% on Thursday.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 5.3% to $130.70 in pre-market trading after the company reported first-quarter financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38452338/microsoft-alphabet-and-3-stocks-to-watch-heading-into-friday">Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday</a>

Pre-Market Outlook

Movers

ACON

CSSE

DXCM

ELWS

FRGT

GOOG

GOOGL

INTC

Kintara Therapeutics, Inc. - Common Stock

KTRA

Nuveen Insured California Premium Fund Ii

NIVF

PCSA

PEGY

SNAP

TVGN

VINC

WORX

Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Tractor Supply Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) reported better-than-expected earnings for its f<a href="https://www.benzinga.com/news/earnings/24/04/38434273/why-tractor-supply-company-shares-are-falling-after-q1-earnings">irst quarter on Thursday.</a>
The company reported first-quarter earnings per share of $1.83, beating the analyst consensus of $1.71. Quarterly revenues of $3.395 billion were in line with the estimates, rising 2.9% year over year, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Comparable store sales, which increased 1.1%, slowed compared to the prior year&nbsp; (2.1% growth for the previous year's first quarter). The gross margin increased 50 basis points to 36.0% from 35.5% in the first quarter of the prior year.
&#8220;For the first quarter, Tractor Supply&#8217;s results were in line with our expectations with positive comparable store sales and robust earnings growth. I want to thank our more than 50,000 Team Members for their enduring commitment to living our Mission and Values and providing exceptional customer service, which allowed us to deliver solid financial performance in the first quarter. We saw several positive signs in our business during the quarter, including ongoing market share gains, transaction growth and strength in big ticket sales. Most importantly, we believe that our customer base remains healthy and engaged. We remain confident in our outlook for 2024 given our share gains and the continued scaling of our Life Out Here strategy. We remain committed to disciplined investments to capture the significant long-term growth opportunities in our market,&#8221; said Hal Lawton, President and Chief Executive Officer of Tractor Supply.
Tractor Supply reiterated its FY24 outlook with GAAP EPS of $9.85-10.50 versus the $10.22 estimate. The company sees sales of $14.700 billion-15.100 billion versus the $14.98 billion estimate.
Tractor Supply shares rose 2.8% to close at $265.26 on Thursday.
These analysts made changes to their price targets on Tractor Supply following earnings announcement.
<ul>
<li>Telsey Advisory Group increased the price target on Tractor Supply from $ $275 to $280. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating.</li>
<li>Baird boosted the price target on Tractor Supply from $260 to $285. Baird analyst Justin Kleber maintained an Overweight rating.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38452338/microsoft-alphabet-and-3-stocks-to-watch-heading-into-friday">Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday</a>

Earnings

TSCO

Tractor Supply Company Analysts Raise Their Forecasts Following Upbeat Earnings

Benchmark analyst John Lawrence maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Buy and raises the price target from $256 to $280.

Benchmark Maintains Buy on Tractor Supply, Raises Price Target to $280

Phillips 66 shares are trading lower following a Q1 EPS miss.

CINF

Cincinnati Financial shares are trading higher after the company reported better-than-expected Q1 2024 adjusted EPS and sales.

Scotiabank analyst Jeff Fan maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Sector Perform and lowers the price target from $50 to $47.25.

CMCSA

Scotiabank Maintains Sector Perform on Comcast, Lowers Price Target to $47.25

Baird analyst Luke Junk maintains Visteon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) with a Outperform and lowers the price target from $140 to $137.

Baird Maintains Outperform on Visteon, Lowers Price Target to $137

Wells Fargo analyst Steven Cahall maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Equal-Weight and lowers the price target from $47 to $43.

Wells Fargo Maintains Equal-Weight on Comcast, Lowers Price Target to $43

Baird analyst Richard Eastman maintains Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) with a Outperform and raises the price target from $110 to $120.

Baird Maintains Outperform on Teradyne, Raises Price Target to $120

Benchmark analyst Daniel Kurnos maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Buy and lowers the price target from $115 to $105.

ROKU

Benchmark Maintains Buy on Roku, Lowers Price Target to $105

Baird analyst David Manthey maintains Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) with a Neutral and lowers the price target from $62 to $55.

SRCL

Baird Maintains Neutral on Stericycle, Lowers Price Target to $55

Still too early to add low-quality stocks - Wells Fargo

12 Conviction Picks Beating The S&P, Without Help From The Magnificent 7

AVDE: A Good Option For International Developed Market Equity Exposure

Emerging markets surpassed developed markets in inflows last week - BofA

The Great Paradox Of The U.S. Market

2024 Global Market Outlook - Q2 Update: Pent-Up Exuberance

How Mega-Forces Will Reshape The Macro Regime And Investing

Looking Under The Hood Of Recent Global Small- And Large-Cap Performance

Playing Demographic Divergence Now

AOA: Passive Bond-Equity Allocations Are Questionable

AAAU

ABEQ

ACTV

ACWI

ACWV

AFMC

AFSM

AFTY

AGGY

ALTL

AMGN

ANEW

ARKQ

ASET

ASHR

ASHS

ASHX

AUSF

AVDE

AVDV

AVEM

AVES

AVGO

AVIG

AVUV

BAPR

BBAG

BBEU

BBJP

BECO

BGLD

BKAG

BLES

BMYMP

BNDC

BOND

BOTZ

BUFF

BUYZ

BYLD

BYOB

CARR

CBON

CCSO

CFCV

CHIM

CHIQ

CHIR

CHIU

CHIX

CLRG

CMBS

CNXT

CNYA

COWZ

CQQQ

CRBN

CSCO

DBEF

DBEM

DBEU

DBEZ

DBJP

DDLS

DFEV

DGRO

DIEM

DIVB

DIVS

DTEC

DURA

DWLD

DWMF

DXJS

EAGG

EATV

ECNS

EDOW

EFAX

EJUL

EMCR

EMFM

EMXC

EQRR

ERSX

ESGD

ESGE

ESGG

ESGS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for iShares Core MSCI International Developed Markets ETF (ARCA:IDEV)

Friday, April 20, 2018

Thursday, December 14, 2017

Wednesday, August 02, 2017

Friday, March 24, 2017